CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Feasibility of Partners in Care Program for Caregivers of Patients With Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- NA
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Early Palliative Care for Patients With Haematological Malignancies
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of Venetoclax and AMG 176 in Patients With Relapsed/Refractory Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
CLL1-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Ex-vivo Expanded γδ T-lymphocytes (OmnImmune®) in Patients With Acute Myeloid Leukaemia (AML)
- Status
- COMPLETED
- Phase
- PHASE1
Exploring Disease Immunogenicity and the Immunological Effects of Hypomethylating Agents in Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
MRD-guided Treatment in NPM1mut AML Patients
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Brequinar in Subjects With Relapsed/Refractory Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Dose Escalation Study of Minnelide in Relapsed or Refractory Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Long-term Outcomes for Acute Myeloid Leukemia Patients
- Status
- UNKNOWN
- Phase
- N/A
Cognitive Behavioral Therapy in Helping Patients With Acute Myeloid Leukemia or Lymphoma With Cancer-Related Fatigue
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Fractionated Gemtuzumab Ozogamicin in Treating Measurable Residual Disease in Patients With Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Prexasertib in Combination With MEC in Relapsed/Refractory AML and High Risk MDS - a Phase I Trial
- Status
- TERMINATED
- Phase
- PHASE1
Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Microbiota Changes in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy
- Status
- COMPLETED
- Phase
- N/A
Enasidenib (AG-221) Maintenance Post Allogeneic HCT in Patients With IDH2 Mutation
- Status
- RECRUITING
- Phase
- PHASE2
Pinometostat With Standard Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and MLL Gene Rearrangement
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2